On Tuesday, the Journal of the American Medical Association released results from a study on adverse drug events. The study examined nearly 42,600 cases from the National Electronic Injury Surveillance System — Cooperative Adverse Drug Event Surveillance project and found, in part, that the rate of ER visits of adults aged 65 years and older was three times that of those 65 and younger (9.7 visits per 1,000 individuals compared with 3.1, respectively.) Dig into more of the highlights in this Pharmalot story from Ed Silverman. According to the CDC, 11.9 percent of ER visits result in hospital admissions. It’s certainly not a brand new story, but it does highlight the opportunity for pharmacists to better engage with physicians and patients as a valuable part of the care team.
At an annual price tag of $27 billion to service 70 million Medicaid outpatients, it’s no wonder all eyes in political circles are on drug pricing. But which drugs are actually costing the most? Results on a per prescription basis from Kaiser Commission research may surprise you. Still, even this study is done using list prices—a guidepost at best, as you well know. It remains questionable whether sharing data at this level does much to “expose the bad actors and give patients and taxpayers crucial information to make smarter choices.”
Here are few stories we came across this week that you might find interesting: